Genmab A/S | 305.5800 / +2.22% |
Date/Time | 05/23 / 21:53 |
Chg. / Chg.(%) | 6.6300 / +2.22% |
Bid | - |
Ask | - |
Open | 306.8100 |
Previous Close | 298.9500 |
High | 313.4200 |
Low | 305.0000 |
Volume [USD] | 100,090.6200 |
Volume [Units] | 325 |
Price fixings | 32 |
ISIN | DK0010272202 |
Security | GNMSF |
Exchange | Nasdaq Other OTC |
Type | Stock |
Other Exchanges
Exchange | Last | Volume | |
---|---|---|---|
Cboe Europe .. | 2,141.50 | ![]() |
23,693 |
Turquoise | 2,142.00 | ![]() |
2,994 |
London Inter.. | 2,135.0 | ![]() |
1,707 |
Cboe Europe .. | 2,144.50 | ![]() |
253 |
Cboe Europe .. | 2,135.00 | ![]() |
107 |
München | 293.50 | ![]() |
0 |
Düsseldorf | 287.80 | ![]() |
0 |
Hannover | 285.60 | ![]() |
0 |
Frankfurt | 286.2000 | ![]() |
0 |
Berlin | 287.90 | ![]() |
0 |
Quotrix | 286.5000 | ![]() |
|
Lang & Schwa.. | 287.40 | ![]() |
|
Stuttgart | 285.800 | ![]() |
|
gettex | 286.400 | ![]() |
|
OMX Nordic | 2,156.00 | ![]() |
78,081 |
Nasdaq Other.. | 305.5800 | ![]() |
325 |
TradeGate | 296.700 | 5 | |
Vienna Globa.. | 290.60 | 0 | |
Mexico | 7,393.30 | ![]() |
203 |
News
- Pfizer and BioNTech Submit for U.S. Emergency Use Authorization of an Additional Booster Dose of their COVID-19 Vaccine for Older Adults
03/15/2022 / 23:00 - GlobeNewswire - BioNTech and Regeneron Expand Strategic Collaboration to Advance Clinical Development of FixVac and Libtayo® (cemiplimab) Combination in NSCLC
03/08/2022 / 14:27 - GlobeNewswire - Notice to Convene the Annual General Meeting of Genmab A/S
02/24/2022 / 12:01 - GlobeNewswire - PTA-News: Medigene AG: BioNTech and Medigene announce global collaboration to advance T cell receptor immunotherapies against cancer
02/21/2022 / 19:25 - pressetext - BioNTech and Medigene Announce Global Collaboration to Advance T Cell Receptor Immunotherapies Against Cancer
02/21/2022 / 19:25 - GlobeNewswire